AstraZeneca (NASDAQ: $AZN) posted its Q1 2025 earnings on April 29. The stock trades at $70.13. Revenue for the quarter rose 10% year-over-year to $13.59 […]
Tag: AstraZeneca PLC (AZN)
Fusion Pharma (NASDAQ: $FUSN) Soars 97% on AstraZeneca Buyout for $2.4B in Cash
Fusion Pharmaceuticals (NASDAQ: $FUSN), a Canadian biotech, has been acquired by British-Swedish Biotech giant AstraZeneca (NASDAQ: $AZN) in a $2.4 billion cash deal announced on […]